Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Bulletin Du Cancer|January 1, 1988
[Pharmacokinetics of high-dose melphalan (200 mg/m2) in a case of total renal insufficiency]B Tranchand, P Biron, A Mercatello, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 casesC Ardiet, B Tranchand, P Biron, et al.Bulletin Du Cancer|July 1, 1995
[Cytotoxic chemotherapy in elderly patients: present and future]G Freyer, P Maire, C Ardiet, et al.Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990
[Hemodilution and peroperative autotransfusion during harvest for bone marrow graft]J Y Ranchère, B Bruneau, P Gordiani, et al.Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1992
[Pharmacokinetics of methohexital given by constant rate intravenous infusion]B Bally, J F Payen, F Serre-Debeauvais, et al.Bulletin Du Cancer|July 1, 1997
[Bayesian estimation of pharmacokinetic parameters of etoposide]E Evene, E Chatelut, B Tranchand, et al.IET Systems Biology|May 20, 2009
Chemotherapy may be delivered based on an integrated view of tumour dynamicsB Ribba, B You, M Tod, et al.Bulletin Du Cancer|January 1, 1994
[Effect of carboplatin on the pharmacokinetics of melphalan administered intravenously]B Tranchand, C Ardiet, E Bouffet, et al.Investigational New Drugs|January 1, 1995
Phase I and pharmacokinetic study of KW-2149 given by 24 hours continuous infusionL Dirix, G Catimel, R Verdonk, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
High-dose melphalan dosage adjustment: possibility of using a test-doseB Tranchand, Y D Ploin, M P Minuit, et al.Pageof 3